P J Wedlund

Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism

P J Wedlund, W S Aslanian, C B McAllister et al. · Clinical Pharmacology & Therapeutics · 1984 · 264 citations

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.

Kenneth R. Hande, P J Wedlund, Richard M. Noone et al. · PubMed · 1984 · 150 citations

Therapeutic Drug Monitoring, Urology, Medicine +12

A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.

Jayme Bork, Theresa Rogers, P J Wedlund et al. · PubMed · 1999 · 142 citations

A Study of Genetic (<i>CYP2D6</i> and <i>ABCB1</i>) and Environmental (Drug Inhibitors and Inducers) Variables That May Influence Plasma Risperidone Levels

José de León, Margaret T. Susce, R. Martin-du Pan et al. · Pharmacopsychiatry · 2007 · 102 citations

Cyp2d6 Pm Phenotype, Genetics, Plasma Ratios +27

Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.

P J Wedlund, W S Aslanian, E Jacqz et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 96 citations